Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7549-7555

  White, E S ^a   Strom, S R B ^a   Wys, N L ^a   Arenberg, D A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANGIOGENIC FACTOR; CHEMOKINE RECEPTOR CXCR2; MIGRATION INHIBITION FACTOR; NEUTRALIZING ANTIBODY;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CHEMOTAXIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG NON SMALL CELL CANCER; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 0035876935     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7549     Document Type: Article

References (56)

1. Relation of vascular proliferation to tumor growth
2. Switch to the angiogenic phenotype during tumorigenesis
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
5. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
6. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
7. CXC chemokine modulation of angiogenesis: The importance of balance between angiogenic and angiostatic members of the family
8. CXC chemokines and angiogenesis/angiostasis
9. The role of angiogenesis in tumor growth
10. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
11. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
12. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells
13. Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells
14. Tumor induction of VEGF promoter activity in stromal cells
15. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
16. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
17. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma-clinicopathologic correlation
18. Macrophages and microvessel density in tumors of the ovary
19. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: Association with angiogenesis and poor prognosis
20. Macrophage infiltration in human non-small cell lung cancer: The role of CC chemokines
21. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
22. The detection of novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA
23. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
24. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis
25. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis
26. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth
27. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms
28. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
29. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density
30. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
31. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
32. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast co-cultures
33. Interleukin-8 expression by head and neck squamous cell carcinoma
34. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines
35. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines
36. CXC chemokine receptor expression on human endothelial cells
37. Eosinophils and human cancer
38. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
39. Role of the macrophage in angiogenesis-dependent diseases
40. The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8
41. Macrophages, wound repair and angiogenesis
42. Basics of cutaneous wound repair
43. Tumors: Wounds that do not heal
44. Fibrin containing gels induce angiogenesis: Implications for tumor stroma generation and wound healing
45. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
46. Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages
47. MIP-1α as a critical macrophage chemoattractant in murine wound repair
48. The role of the macrophage in wound repair: A study with hydrocortisone and antimacrophage serum
49. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates
50. Adherence-dependent increase in human monocyte PDGF(B) mRNA is associated with increases in c-fos, c-jun, and EGR2 mRNA
51. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
52. Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor-associated macrophages
53. Transforming growth factor-β stimulates urokinase expression in tumor-associated macrophages of the breast
54. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis
55. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: A cellular and molecular analysis
56. MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response